NFSG
ATOS icon

Newbridge Financial Services Group’s Atossa Therapeutics ATOS Stock Holding History

Newbridge Financial Services Group’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-133
Closed -$2K – 1379
2022
Q2 		$2K Hold
133
– – ﹤0.01% 1152
2022
Q1 		$3K Hold
133
– – ﹤0.01% 1178
2021
Q4 		$3K Sell
133
-2,000
-94% -$73.2K ﹤0.01% 1140
2021
Q3 		$104K Buy
+2,133
New +$124K 0.07% 264
2021
Q2 		– Sell
-467
Closed -$15K – 1430
2021
Q1 		$15K Buy
+467
New +$17.1K 0.01% 761

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Newbridge Financial Services Group's ATOS Position: Q3 2022 in Review

Newbridge Financial Services Group sold out of Atossa Therapeutics (ATOS) in Q3 2022, closing a stake of 133 shares — an estimated $2K sold.

Newbridge Financial Services Group first reported a position in ATOS in Q1 2021 and held it in 5 quarters. The position peaked at $104K in Q3 2021. 56 funds tracked by Wall St. Rank hold ATOS as of Q3 2022.

  • Newbridge Financial Services Group reported no remaining Atossa Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 133 Atossa Therapeutics shares in Q3 2022, an estimated $2K.
  • Newbridge Financial Services Group first reported a position in Atossa Therapeutics in Q1 2021 and held it in 5 quarters.
  • Newbridge Financial Services Group's Atossa Therapeutics position peaked at $104K in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2022.

Based on Newbridge Financial Services Group's 13F filing for Q3 2022, filed 13 Oct 2022.